PhytoHealth (TPE:4108) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:4108 PhytoHealth Corp TPE:4108
72 GF Score
Price NT$11.75
GF Value NT$15.95
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is PhytoHealth FFO per Share?

FFO per Share only applies to REITs.

TPE:4108
72GF Score
PhytoHealth Corp TPE:4108
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is PhytoHealth (TPE:4108) Overvalued in 2026?

Based on GuruFocus' analysis, PhytoHealth stock appears to be undervalued. The current stock price of NT$11.75 is trading 26.3% below its estimated GF Value™ of NT$15.95. GuruFocus considers PhytoHealth to be Modestly Undervalued.

Key valuation signals for TPE:4108:

  • FFO per Share:
  • GF Value™: NT$15.95 vs. price of NT$11.75 (26.3% below fair value)
  • GF Score™: 72/100 with 2 warning signs

No single metric tells the full story. See the TPE:4108 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PhytoHealth Business Description

Address Fuxing North Road, No. 167, 5th Floor - 1, Zhongshan District, Taipei, TWN, 104
PhytoHealth Corp engages in the research and development, production, manufacture, and sale of pharmaceutical drugs, cosmetics, Class B drugs, and dietary supplements. The company's product portfolio comprises White Blood Crystals Injection, White Pain Relief Soft Capsules, WhiteGilead, and White AminoSpeed supplements. Additionally, it is developing PHN031 (White Bone) for the prevention of osteoporosis; PHN033 (White Sugar) for the treatment of diabetic nephropathy; PHN016 for cancer treatment; and PHN017 for the treatment of cytokine storm. The company's reportable operating segments are: Pharmaceutical drugs and dietary supplement, which generate maximum revenue, Medical diagnostic products, and Precision medical equipment. Geographically, it derives maximum revenue from Taiwan.
72GF Score

Get the complete analysis for TPE:4108

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$11.75
Price
NT$15.95
GF Value